Carl Zeiss buys IOL manufacturer Aaren Scientific

Article

Carl Zeiss Meditec AG announced it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a U.S.-based manufacturer of intraocular lenses (IOLs).

Germany-Carl Zeiss Meditec AG announced it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a U.S.-based manufacturer of intraocular lenses (IOLs). Aaren Scientific, headquartered in Ontario, CA, has been manufacturing IOLs for more than two decades.

The majority of shares in Aaren Scientific were owned by a private investment company as well as other investors, including the CEO and co-founder of Aaren Scientific, Rick Aguilera. Aguilera and the management team will remain after the transaction.

Aaren Scientific was the first manufacturer of IOLs in the U.S. to receive a CE registration and is well known for its innovative R&D capabilities. The company currently has 235 employees. In 2012, Aaren Scientific achieved total revenues of approximately $20 million, primarily generated outside of the U.S. The company will be integrated into the Strategic Business Unit (SBU) Surgical Ophthalmology of Carl Zeiss Meditec and complements the existing Zeiss IOL development and manufacturing sites in Berlin, Germany, and La Rochelle, France. The SBU Surgical Ophthalmology has continuously reported above market growth rates for the last 3-4 years driven by strong demand for innovative IOLs.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Patricia Buehler, MD, MPH, at ASCRS 2025
Brett Bielory, MD, at ASCRS 2025
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia.
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Matt Jones, OD; Matt Burns; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
© 2025 MJH Life Sciences

All rights reserved.